Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells

FEBS Journal

Volumn 277, Issue 16, 2010, Pages 3437-3448

  Banerjee, Mithu ^a   Singh, Parminder ^a   Panda, Dulal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

apoptosis; BubR1; combination study; delayed mitosis; dynamic instability

Indexed keywords

BUB1 RELATED PROTEIN; CURCUMIN; KINESIN; PACLITAXEL; PROTEIN MAD2; VINBLASTINE;

ANAPHASE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL STRAIN MCF 7; CENTROMERE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; METAPHASE; MICROTUBULE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; FEMALE; HUMANS; KINESIN; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; PROTEIN STABILITY; PROTEIN TRANSPORT; TIME FACTORS; TUBULIN;

EID: 77955261430     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07750.x     Document Type: Article

References (52)

1. Shishodia S, Chaturvedi MM Aggarwal BB (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31, 243 305.
2. Hatcher H, Planalp R, Cho J, Torti FM Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65, 1631 1652.
3. Chun KS, Sohn Y, Kim HS, Kim OH, Park KK, Lee JM, Moon A, Lee SS Surh YJ (1999) Anti-tumor promoting potential of naturally occurring diarylheptanoids structurally related to curcumin. Mutat Res 428, 49 57.
4. Shankar TN, Shantha NV, Ramesh HP, Murthy IA Murthy VS (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 18, 73 75.
5. Aggarwal BB, Kumar A Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23, 363 398.
6. Dohare P, Garg P, Jain V, Nath C Ray M (2008) Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav Brain Res 193, 289 297.
7. Sahu RP, Batra S Srivastava SK (2009) Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 100, 1425 1433.
8. Liu E, Wu J, Cao W, Zhang J, Liu W, Jiang X Zhang X (2007) Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol 85, 263 270.
9. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S Delage C (1998) Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129, 111 116.
10. Choudhuri T, Pal S, Agwarwal ML, Das T Sa G (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512, 334 340.
11. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV Reddy BS (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59, 597 601.
12. Gupta KK, Bharne SS, Rathinasamy K, Naik NR Panda D (2006) Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS J 273, 5320 5332.
13. Holy JM (2002) Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518, 71 84.
14. Wolanin K, Magalska A, Mosieniak G, Klinger R, McKenna S, Vejda S, Sikora E Piwocka K (2006) Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells. Mol Cancer Res 4, 457 469.
15. Dempe JS, Pfeiffer E, Grimm AS Metzler M (2008) Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol Nutr Food Res 52, 1074 1081.
16. Thomas SL, Zhong D, Zhou W, Malik S, Liotta D, Snyder JP, Hamel E Giannakakou P (2008) EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Cell Cycle 7, 2409 2417.
17. Desai A Mitchison TJ (1997) Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13, 83 117.
18. Walczak CE Heald R (2008) Mechanism of mitotic spindle and function. Int Rev Cytol 265, 111 158.
19. Rathinasamy K Panda D (2008) Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53. Biochem Pharmacol 76, 1669 1680.
20. Mohan R Panda D (2008) Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest. Cancer Res 68, 6181 6189.
21. Kamath K Jordan MA (2003) Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest. Cancer Res 63, 6026 6031.
22. Yvon AM, Wadsworth P Jordan MA (1999) Paclitaxel suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 10, 947 959.
23. Chen RH (2002) BubR1 is essential for kinetochore localization of other spindle checkpoint proteins and its phosphorylation requires Mad1. J Cell Biol 158, 487 496.
24. Skoufias DA, Andreassen PR, Lacroix FB, Wilson L Margolis RL (2001) Mammalian Mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc Natl Acad Sci USA 98, 4492 4497.
25. Tyagi AK, Singh RP, Agarwal C, Chan DC Agarwal R (2002) Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis. Clin Cancer Res 8, 3512 3519.
26. Chou TC Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22, 27 55.
27. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL Mitchison TJ (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971 974.
28. Kwok BH, Yang JG Kapoor TM (2004) The rate of bipolar spindle assembly depends on the microtubule-gliding velocity of the mitotic kinesin Eg5. Curr Biol 14, 1783 1788.
29. Prinz H, Ishii Y, Hirano T, Stoiber T, Camacho Gomez JA, Schmidt P, Düssmann H, Burger AM, Prehn JH, Günther EG et al. (2003) Novel benzylidene-9(10H)-HMBAs as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. J Med Chem 46, 3382 3394.
30. Wood DL, Panda D, Wiernicki TR, Wilson L, Jordan MA Singh JP (1997) Inhibition of mitosis and microtubule function through direct tubulin binding by a novel antiproliferative naphthopyran LY290181. Mol Pharmacol 52, 437 444.
31. Giannakakou P, Robey R, Fojo T Blagosklonny MV (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20, 3806 3813.
32. Torres K Horwitz SB (1998) Mechanisms of Paclitaxel-induced cell death are concentration dependent. Cancer Res 58, 3620 3626.
33. Meraldi P, Draviam VM Sorger PK (2004) Timing and checkpoints in the regulation of mitotic progression. Dev Cell 7, 45 60.
34. Sudo T, Nitta M, Saya H Ueno NT (2004) Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 64, 2502 2508.
35. Srivastava P Panda D (2007) Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J 274, 4788 4801.
36. Chen RH, Waters JC, Salmon ED Murray AW (1996) Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. Science 274, 242 246.
37. Rieder CL Cole R (2000) Microtubule disassembly delays the G2-M transition in vertebrates. Curr Biol 10, 1067 1070.
38. Rieder CL Maiato H (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7, 637 651.
39. DeLuca JG, Moree B, Hickey JM, Kilmartin JV Salmon ED (2002) hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells. J Cell Biol 159, 549 555.
40. Chari NS, Pinaire NL, Thorpe L, Medeiros LJ, Routbort MJ McDonnell TJ (2009) The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death. Apoptosis 14, 336 347.
41. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF Fojo T (2002) Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99, 10855 10860.
42. Kastan MB, Canman CE Leonard CJ (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14, 3 15.
43. Estève MA, Carré M Braguer D (2007) Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targets 7, 713 729.
44. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W et al. (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895 2900.
45. Lao CD, Ruffin MT IV., Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL Brenner DE (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10.
46. Sarkar FH Li Y (2006) Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66, 3347 3350.
47. Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D Arber N (2005) Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 11, 6738 6744.
48. Rathinasamy K Panda D (2006) Suppression of microtubule dynamics by benomyl decreases tension across kinetochore pairs and induces apoptosis in cancer cells. FEBS J 273, 4114 4128.
49. Voigt W (2005) Sulforhodamine B assay and chemosensitivity. Methods Mol Med 110, 39 48.
50. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248 254.
51. Walker RA, O'Brien ET, Pryer NK, Soboeiro MF, Voter WA, Erickson HP Salmon ED (1988) Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies. J Cell Biol 107, 1437 1448.
52. Chou TC Talalay P (1983) Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol Sci 4, 450 454.